We start by engaging with your technical team to understand your antibody formulation, its clinical stage, and any known stability or particulate issues.
Antibody Subvisible Particle Detection Service
Ensure Purity, Perfect Your Antibody Formulation
Subvisible particles in antibody therapeutics can trigger immune responses, affect stability, and compromise efficacy. Advanced detection methods, including micro-flow imaging and fluorescence-based membrane analysis, enable precise particle sizing, counting, and morphological classification. Literature shows these approaches outperform traditional light obscuration, providing sensitive, reproducible data critical for biopharmaceutical quality assurance. Are you facing stability challenges, immunogenicity risks, or regulatory compliance concerns due to subvisible particles in antibody formulations? Antibody subvisible particle detection service at Creative Biolabs helps you safeguard product quality, reduce patient risk, and meet stringent pharmacopeia standards through advanced micro-flow imaging, fluorescence membrane microscopy, and high-throughput particle characterization technologies.
Our Antibody Subvisible Particle Detection Service includes:
- Quantification of particles in the 1–100 µm range.
- Differentiation of protein aggregates from silicone oil and foreign particulates.
- Particle morphology analysis for aggregation root-cause insights.
- Real-time monitoring for formulation and process changes.
- Batch release and stability study support
- Expert interpretation to guide formulation refinement or manufacturing adjustments.
We deliver clear, detailed subvisible particle profiles that help you anticipate and resolve quality issues. Our data supports stability claims, identifies aggregation risks, and ensures your antibody products meet global safety expectations.
Discover How We Can Help – Request a Consultation.
Strategies
We combine orthogonal detection platforms to ensure robust, reliable subvisible particle profiling:
- High-resolution imaging for morphology-based particle classification.
- Fluorescence-based detection to distinguish proteinaceous from non-protein particles.
- Small-volume analysis for precious biologics with limited availability.
- Method optimization tailored to your formulation and excipients.
- Integration with stability and stress testing programs.
Workflow
Project Consultation & Requirement Definition
Custom Method Development & Validation
We adapt imaging and fluorescence parameters to suit the unique optical and chemical characteristics of your formulation. Validation includes precision, accuracy, and repeatability testing, ensuring reproducibility for both internal QA and external submission purposes.
Sample Preparation & Contamination Control
Our controlled environment protocols minimize extrinsic contamination, preserving the authenticity of particle profiles. Specialized sample handling equipment is employed to accommodate viscous or highly concentrated biologics.
Comprehensive Particle Analysis
Using advanced micro-flow imaging and fluorescence membrane microscopy, we assess particle size distribution, morphology, and composition. Orthogonal methods confirm particle type and origin, enhancing confidence in results.
Data Integration & Comparative Evaluation
We compile results from multiple analytical platforms, comparing particle profiles across different batches, storage conditions, or manufacturing lots to identify trends and consistency in quality.
Interpretation & Cause Investigation
We correlate particle characteristics with potential sources, such as formulation components, container closure interactions, or processing steps, to guide corrective actions. This step often involves comparative analysis between control and stressed samples.
Required Materials
- Detailed antibody formulation data, including concentration, buffer composition, excipients, and known stabilizers, to inform method optimization.
- Any available stability profiles, prior particulate data, or stress study results, enabling us to target likely sources of subvisible particles.
- Defined sample volume and container type, with clarity on intended storage and handling conditions to replicate real-use scenarios.
- Manufacturing and filling process summaries that may identify potential particulate introduction points.
- Information on container closure system materials (e.g., glass, polymer, elastomeric components) to assess interaction-related particle formation.
Highlights
Complete Particle Detection
Tailored for antibody therapeutics, this solution ensures end-to-end particle detection and integrates seamlessly into existing QC workflows, providing reliable results throughout the production process.
Multi-Platform Performance
Combining multiple detection platforms, this system delivers unmatched sensitivity, specificity, and confidence in results across various formulations and conditions.
Low-Volume Sample Analysis
Capable of analyzing small, high-value samples, it provides statistically reliable data without compromising quality, ideal for sensitive or rare materials.
Morphological Characterization
High-resolution imaging helps identify the root causes of aggregation or contamination, offering deeper insights into formulation issues.
Experience the Creative Biolabs Advantage – Get a Quote Today.
Publication
Experimental Raman spectra of isolated particles from Mab1 and Mab2 formulations reveal distinct spectral signatures that correspond to differences in particle composition. Characteristic peaks associated with protein structures and excipient residues provide clear differentiation between proteinaceous aggregates and other particulate matter. The data indicate that certain spectral features align with chemical changes linked to polysorbate 20 degradation, offering valuable clues about the origin and nature of particles in each formulation. This spectral profiling approach enhances understanding of degradation pathways and supports targeted formulation improvements.
Fig.1 Raman spectral profiles obtained from isolated particles in Mab1 and Mab2 formulations.1
Customer Reviews
- "Precise particle characterization. Using Creative Biolabs' subvisible particle detection, we identified silicone oil contamination in our prefilled syringes, allowing rapid process correction and avoiding batch rejection." - Dr. T***
- "High sensitivity for small volumes. Their ability to detect protein aggregates in minimal sample quantities was invaluable for our early-stage formulation work." - Dr. E***
- "Regulatory-ready documentation. The detailed particle analysis reports supported our stability program and passed agency review without additional queries." - Dr. R***
FAQs
What particle size range can you detect?
We quantify particles from approximately 1 to 100 µm, with morphological classification for deeper insights.
Can you distinguish between protein and non-protein particles?
Yes, fluorescence-based analysis differentiates protein aggregates from silicone oil or other contaminants.
Is the method suitable for small sample volumes?
Our platforms can perform complete analyses using as little as a few microliters of sample.
Can particle detection be integrated with stability studies?
Absolutely, we frequently combine this service with accelerated and real-time stability testing.
Extended Services
Antibody-Oligonucleotide Conjugate (AOC) Development Service
We create targeted AOCs that merge antibody specificity with oligonucleotide function. Services include conjugation optimization, stability testing, and functional validation for precise delivery.
Learn More →Antibody-Lipid Nanoparticle (LNP) Development Service
We develop antibody-modified LNPs for targeted nucleic acid or payload delivery. This includes formulation design, surface modification, and performance evaluation in relevant models.
Learn More →Our integrated services provide a complete quality control solution for antibody-based therapeutics, ensuring product integrity from development through market release. Contact Our Team for More Information and to Learn more.
Reference
- Saggu, Miguel et al. "Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway." Pharmaceutical research vol. 32,9 (2015): 2877-88. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1007/s11095-015-1670-x
For research use only. Not intended for any clinical use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
